Our competitive edge is created by deep insight into the industries in which we operate and our knowledge of the trends and activities that affect our clients. In our chosen sectors, we regularly publish reviews of the dynamics and strategic initiatives driving M&A activity, private equity investment and debt capital deployment.
For more information on our research output, please contact Keith Pickering on +44 (0) 20 7246 0500 or email@example.com
Our top 5 deals illustrating the trends that have underpinned 2017 M&A activity in healthcare
Adobe Acrobat file - 0.3 mb
The UK’s decision to leave the EU represents a major opportunity for the country’s dynamic and world-leading pharmaceutical sector – despite warnings that Brexit could prompt pharma companies to quit the UK.
Adobe Acrobat file - 0.2 mb
The inaugural Catalyst Pharma Fast 50, our list of the 50 fastest-growing privately owned pharmaceutical companies in the UK in 2016
Adobe Acrobat file - 3.4 mb
The emergence of US trade buyers has energised the exit environment for owner managers and investors. We expect further consolidation over the next few years.
Adobe Acrobat file - 0.7 mb
The past twelve months have seen a continuation of strong overall healthcare activity. Deal volumes across each sector have risen with pharmaceuticals recording a significant increase.
Adobe Acrobat file - 1.4 mb